ABSTRACTThe potential use of radion

ABSTRACTThe potential use of radionuclides in therapy has been recognized for many decades. A number of radionuclides, such as iodine-131 (131I), phosphorous-32 (32P), strontium-90 (90Sr), and yttrium-90 (90Y), have been used successfully for the treatment of many benign and malignant disorders. Recently, the rapid growth of this branch of nuclear medicine has been stimulated by the introduction of a number of new radionuclides and radiopharmaceuticals for the treatment of metastatic bone pain and neuroendocrine and other malignant or non-malignant tumours. Today, the field of radionuclide therapy is enjoying an exciting phase and is poised for greater growth and development in the coming years. For example, in Asia, the high prevalence of thyroid and liver diseases has prompted many novel developments and clinical trials using targeted radionuclide therapy. This paper reviews the characteristics and clinical applications of the commonly available therapeutic radionuclides, as well as the problems and issues involved in translating novel radionuclides into clinical therapies.

結果 (繁體中文) 1:

抽象
The potential use of radionuclides in therapy has been recognized for many decades. A number of radionuclides, such as iodine-131 (131I), phosphorous-32 (32P), strontium-90 (90Sr), and yttrium-90 (90Y), have been used successfully for the treatment of many benign and malignant disorders. Recently, the rapid growth of this branch of nuclear medicine has been stimulated by the introduction of a number of new radionuclides and radiopharmaceuticals for the treatment of metastatic bone pain and neuroendocrine and other malignant or non-malignant tumours. Today, the field of radionuclide therapy is enjoying an exciting phase and is poised for greater growth and development in the coming years. For example, in Asia, the high prevalence of thyroid and liver diseases has prompted many novel developments and clinical trials using targeted radionuclide therapy. This paper reviews the characteristics and clinical applications of the commonly available therapeutic radionuclides, as well as the problems and issues involved in translating novel radionuclides into clinical therapies.

結果 (繁體中文) 2:

抽象
放射性核素在治療中的潛在用途已經認識到幾十年了。一些放射性核素，如碘-131（131I），磷-32（32P），鈈-90（90Sr）和ytrium-90（90Y），已成功用於治療許多良性和惡性疾病。最近，這一核醫學分支的迅速發展受到一些新的放射性核素和放射性藥物的刺激，用於治療轉移性骨痛和神經內分泌和其他惡性或非惡性腫瘤。今天，放射性核素治療領域正處於一個激動人心的階段，並準備在未來幾年取得更大的增長和發展。例如，在亞洲，甲狀腺和肝臟疾病的高患病率促使了許多新的發展和臨床試驗，使用有針對性的放射性核素治療。本文綜述了常用治療放射性核素的特點和臨床應用，以及將新型放射性核素轉化為臨床治療所涉及的問題和問題。

結果 (繁體中文) 3:

摘要
幾十年來，人們認識到放射性核素在治療中的潜在用途。碘-131（131I）、磷-32（32P）、鍶-90（90Sr）、釔-90（90Y）等多種放射性核素已成功用於治療多種良惡性疾病。近年來，核醫學這一分支的迅速發展受到了許多新的放射性核素和治療轉移性骨痛和神經內分泌等惡性或非惡性腫瘤的放射性藥物的刺激。今天，放射性核素治療領域正處於一個令人興奮的階段，並準備在未來幾年中取得更大的增長和發展。例如，在亞洲，甲狀腺和肝臟疾病的高發率促使許多新的發展和使用靶向放射性核素治療的臨床試驗。本文綜述了常用治療放射性核素的特點和臨床應用，以及將新的放射性核素轉化為臨床治療所涉及的問題。